CLINICAL TRIALS PROFILE FOR SALONPAS
✉ Email this page to a colleague
All Clinical Trials for SALONPAS
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05106400 ↗ | Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2021-07-01 | The study is designed to evaluate and compare the clinical adhesion performance of the ZTlido (Lidocaine Topical System) 1.8% of Scilex Pharmaceuticals Inc. (Reference) versus Salonpas (Lidocaine Patch 4%), Aspercreme (Lidocaine Patch 4%) and IcyHot (Lidocaine 4% + Menthol 1% Patch), on the Mid to upper back while being worn for 12 hours in healthy adult human subjects. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SALONPAS
Condition Name
Clinical Trial Locations for SALONPAS
Trials by Country
Clinical Trial Progress for SALONPAS
Clinical Trial Phase
Clinical Trial Sponsors for SALONPAS
Sponsor Name